Research suggests sustained weight loss with semaglutide requires ongoing treatment in most patients, with weight regain occurring within months after discontinuation
In researching her own condition, she did a huge analysis of a medical records database and found an interesting fact: Those fibromyalgia patients who were on a GLP-1 were less likely to use opioids, and had fewer reports of pain, fatigue, and feeling bad
BTIG analysts Marie Thibault and Sam Eiber seem to agree with that sentiment on a broader scale
GLP-1s dont replace the need for nutrition support, behavior change, mental health resources, and ongoing engagement
Bringing the answers ready saves time and helps the doctor say "yes" faster
Semaglutide can cause some side effects, but each person's experience can be slightly different